A multicultural group practicing yoga together in a bright studio

bmiMD vs Direct Meds: GLP-1 Comparison 2026

bmiMD vs Direct Meds: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated September 3, 20264 min read

Quick answer

bmiMD typically wins on sticker price for compounded GLP-1. Both prescribe compounded medication, so compare them on the specific product, plan term, and terms you'd actually be buying rather than on program positioning.

Side-by-side comparison

Feature	bmiMD	Direct Meds
Best for	Low-cost compounded GLP-1 with a named 503A pharmacy and flat per-dose pricing	Multiple compounded formats (injection and sublingual)
Medication type	Compounded semaglutide (GLP-1) and compounded tirzepatide (GLP-1/GIP), once-weekly at-home injection	Compounded semaglutide and tirzepatide
Pricing model	Cash-pay subscription with commitment tiers (1/3/6/12-month); 'same price at every dose'; provider visit included; Subscribe & Save 10%	All-inclusive monthly price by medication format
Semaglutide price	Compounded, $119–$159/mo ('Same price at every dose'): 12-mo $119, 6-mo $129, 3-mo $149, 1-mo $159. Verified 2026-09-03 in a real browser on bmimd.com/compounded-semaglutide/ — an across-the-board increase from the prior $99–$129 ladder (recorded in the 2026-08-21 priceHistory entry).	From $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF')
Tirzepatide price	Compounded, $179–$249/mo: 12-mo $179, 6-mo $189, 3-mo $229, 1-mo $249. Verified 2026-09-03 in a real browser on bmimd.com/compounded-tirzepatide/ — an across-the-board increase from the prior $139–$179 ladder (recorded in the 2026-08-21 priceHistory entry); the tirzepatide page no longer carries the 'same price at every dose' line (the semaglutide page still does).	From $299/mo (sublingual) to $399/mo (injection), all-inclusive, verified 2026-07-25
Key watchout	The lowest advertised rate ($119/mo semaglutide, $179/mo tirzepatide) is the 12-month commitment tier; month-to-month is $159/mo semaglutide and $249/mo tirzepatide (prices rose across the board, verified 2026-09-03). The semaglutide page still says 'Same price at every dose'; the tirzepatide page no longer carries that line.	Pricing varies by format and page, product-page 'all-inclusive' rates differ from homepage promo cards; confirm your format's rate at checkout
Price checked	Checked by a person September 3, 2026	Checked by a person July 25, 2026

When to choose bmiMD

You want low-cost compounded semaglutide or tirzepatide with medication and provider visit included
You value a named, disclosed 503A compounding pharmacy (Precision Compounding Pharmacy) and flat 'same price at every dose'
You want the lowest rate via a 12-month commitment (or month-to-month at a higher price)
You want HSA/FSA eligibility and free shipping

Check current bmiMD pricing →

When to choose Direct Meds

You want a specific format, injection or sublingual, at a clear all-inclusive price
You're already familiar with GLP-1 dosing and side-effect management
You don't need a coach or a heavy-touch clinical team
You want a no-frills, predictable monthly bill

Check current Direct Meds pricing →

Full reviews

Frequently asked questions

Is bmiMD cheaper than Direct Meds?

bmiMD starts lower on semaglutide (Compounded, $119–$159/mo ('Same price at every dose'): 12-mo $119, 6-mo $129, 3-mo $149, 1-mo $159. Verified 2026-09-03 in a real browser on bmimd.com/compounded-semaglutide/ — an across-the-board increase from the prior $99–$129 ladder (recorded in the 2026-08-21 priceHistory entry).). bmiMD starts lower on tirzepatide (Compounded, $179–$249/mo: 12-mo $179, 6-mo $189, 3-mo $229, 1-mo $249. Verified 2026-09-03 in a real browser on bmimd.com/compounded-tirzepatide/ — an across-the-board increase from the prior $139–$179 ladder (recorded in the 2026-08-21 priceHistory entry); the tirzepatide page no longer carries the 'same price at every dose' line (the semaglutide page still does).). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, bmiMD or Direct Meds?

bmiMD starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are bmiMD and Direct Meds compounded or brand-name?

bmiMD offers compounded semaglutide (glp-1) and compounded tirzepatide (glp-1/gip), once-weekly at-home injection. Direct Meds offers compounded semaglutide and tirzepatide. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from bmiMD to Direct Meds?

Yes, switching between bmiMD and Direct Meds is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare bmiMD and Direct Meds to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, $119–$159/mo ('Same price at every dose'): 12-mo $119, 6-mo $129, 3-mo $149, 1-mo $159. Verified 2026-09-03 in a real browser on bmimd.com/compounded-semaglutide/ — an across-the-board increase from the prior $99–$129 ladder (recorded in the 2026-08-21 priceHistory entry). and $249/mo (sublingual) to $297/mo (injection), all-inclusive, verified 2026-07-25 on Direct Meds' own product pages ('$249.00 / month … Billed Every Month', '0% OFF') are starting tiers, not your guaranteed long-term cost.